Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Akebia Therapeutics (AKBA) over the last 9 years, with Q3 2025 value amounting to 0.63.

  • Akebia Therapeutics' Asset Utilization Ratio rose 101911.99% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 101911.99%. This contributed to the annual value of 0.69 for FY2024, which is 197081.11% up from last year.
  • Per Akebia Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.63 for Q3 2025, which was up 101911.99% from 0.62 recorded in Q2 2025.
  • Over the past 5 years, Akebia Therapeutics' Asset Utilization Ratio peaked at 0.85 during Q1 2023, and registered a low of 0.07 during Q3 2024.
  • For the 5-year period, Akebia Therapeutics' Asset Utilization Ratio averaged around 0.45, with its median value being 0.51 (2022).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 10868.21% in 2024, then soared by 615401.74% in 2025.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Asset Utilization Ratio stood at 0.37 in 2021, then soared by 81.92% to 0.68 in 2022, then tumbled by 93.83% to 0.04 in 2023, then soared by 1684.85% to 0.75 in 2024, then decreased by 15.3% to 0.63 in 2025.
  • Its Asset Utilization Ratio was 0.63 in Q3 2025, compared to 0.62 in Q2 2025 and 0.7 in Q1 2025.